BFRG BULLFROG AI HOLDINGS

BullFrog AI to Participate at the H.C. Wainwright 26th Annual Global Investment Conference

BullFrog AI to Participate at the H.C. Wainwright 26th Annual Global Investment Conference

GAITHERSBURG, Md., Aug. 26, 2024 (GLOBE NEWSWIRE) -- BullFrog AI Holdings, Inc. (NASDAQ: BFRG; BFRGW) ("BullFrog AI" or the "Company"), a leader in AI-driven drug discovery, announced today that the Company will participate in the H.C. Wainwright 26th Annual Global Investment Conference being held in New York City.

Interested parties may access live and archived webcasts of these events on the company’s investor relations website at: . The Company’s presentation by Vin Singh, Chief Executive Officer, will be available on demand commencing on September 9, 2024, at 7:00am ET.

About BullFrog AI:

BullFrog AI leverages Artificial Intelligence and machine learning to advance drug discovery and development. Through collaborations with leading research institutions, BullFrog AI uses causal AI in combination with its proprietary bfLEAP™ platform to analyze complex biological data, aiming to streamline therapeutics development and reduce failure rates in clinical trials. For more information, visit BullFrog AI at .

Contact:

Investors

Dave Gentry

RedChip Companies, Inc.



1-407-644-4256

SOURCE: BullFrog AI Holdings, Inc.



EN
26/08/2024

Underlying

BFRGBULLFROG AI HOLDINGS

To request access to management, click here to engage with our
partner Phoenix-IR's CorporateAccessNetwork.com

Reports on BULLFROG AI HOLDINGS

 PRESS RELEASE
Free
BFRG BULLFROG AI HOL...

BullFrog AI to Unveil New Precision AI Capability

BullFrog AI to Unveil New Precision AI Capability New capabilities to be launched on March 25Unique technology bolsters BullFrog AI’s end-to-end AI intelligence workflow with a scenario-based decision engineAdvances current AI decision tools by clearly defining clinical trial strategies and building diversified, risk-balanced R&D portfolios GAITHERSBURG, Md., Feb. 04, 2026 (GLOBE NEWSWIRE) -- BullFrog AI Holdings, Inc. (NASDAQ: BFRG; BFRGW) ("BullFrog AI" or the "Company"), a technology company using artificial intelligence (“AI”) and machine learning to turn complex biomedical data into...

February 4, 2026 1 EN
 PRESS RELEASE
Free
BFRG BULLFROG AI HOL...

BullFrog AI on Data Harmonization: The Hidden Prerequisite for Reliabl...

BullFrog AI on Data Harmonization: The Hidden Prerequisite for Reliable AI/ML in Life Sciences White paper discusses how BullFrog AI’s bfPREP™ embodies data harmonization, enabling biopharma organizations to convert noisy, document-heavy data into standardized, AI-ready datasets GAITHERSBURG, Md., Jan. 27, 2026 (GLOBE NEWSWIRE) -- BullFrog AI Holdings, Inc. (NASDAQ: BFRG; BFRGW) ("BullFrog AI" or the "Company"), a technology company using artificial intelligence (“AI”) and machine learning to turn complex biomedical data into actionable insights, publishes a white paper titled, “Data H...

January 27, 2026 1 EN
 PRESS RELEASE
Free
BFRG BULLFROG AI HOL...

BullFrog AI-Driven Precision Oncology Analytics Identifies 3x Increase...

BullFrog AI-Driven Precision Oncology Analytics Identifies 3x Increase in Overall Survivability in Patient Subgroups through Key Biomarkers in Pancreatic Cancer Company’s bfLEAP® platform successfully identified treatment effect heterogeneity and possible early predictors of outcomes in pancreatic cancer in data to be presented at ASCO GI GAITHERSBURG, Md., Jan. 06, 2026 (GLOBE NEWSWIRE) -- BullFrog AI Holdings, Inc. (NASDAQ: BFRG; BFRGW) ("BullFrog AI" or the "Company"), a technology company using artificial intelligence (“AI”) and machine learning to turn complex biomedical data into ...

January 6, 2026 1 EN
 PRESS RELEASE
Free
BFRG BULLFROG AI HOL...

BullFrog AI Publishes Annual Letter to Shareholders

BullFrog AI Publishes Annual Letter to Shareholders Highlights significant progress in 2025 and outlines commercial priorities and potential catalysts entering 2026 GAITHERSBURG, Md., Dec. 30, 2025 (GLOBE NEWSWIRE) --  (NASDAQ: BFRG; BFRGW) ("BullFrog AI" or the "Company"), a technology-enabled drug development company using artificial intelligence (“AI”) and machine learning to enable the successful development of pharmaceuticals and biologics, today announced the release of its annual letter to shareholders, which highlights progress made during 2025 and outlines key priorities and po...

December 30, 2025 1 EN
 PRESS RELEASE
Free
BFRG BULLFROG AI HOL...

BullFrog AI Publishes Whitepaper on AI in Bioinformatics: Turning Comp...

BullFrog AI Publishes Whitepaper on AI in Bioinformatics: Turning Complex Data into Actionable Insights New publication details how BullFrog Data Networks® and bfLEAP® technology address fundamental AI challenges in drug discovery and development GAITHERSBURG, Md., Nov. 18, 2025 (GLOBE NEWSWIRE) --  (NASDAQ: BFRG; BFRGW) ("BullFrog AI" or the "Company"), a technology-enabled drug development company using artificial intelligence (“AI”) and machine learning to enable the successful development of pharmaceuticals and biologics, today announced the publication of a new whitepaper titled “A...

November 18, 2025 1 EN

ResearchPool Subscriptions

Get the most out of your insights

Get in touch